Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Airway Management Devices Market , By Type (Infraglottic Airway Management Devices, Supraglottic Airway Management Devices, Resuscitators, Laryngoscopes, Others), By End-use (Operating Rooms, Emergency Care, Departments, Intensive Care Units, Others), By Patient Age (Adult Patient, Pediatric Patient): Global Opportunity Analysis and Industry Forecast, 2019–2026

  • RES4072067
  • 170 Pages
  • February 2020
  • Healthcare
Download Sample    Get Discount   
 
The airway management devices market size was more than $ 1,230.8 million in 2018 and is estimated to witness a lucrative growth of over 7.4% during the forecast period.

Airway management devices include a set of drills and medical procedures to relieve and prevent airway barriers. The devices create an open pathway for exchange of air between lungs and the atmosphere. The obstruction of air can be caused due to tongue, an object or tissue stuck in the esophagus, organ bodily fluids such as blood and gastric content.

Increasing chronic respiratory diseases, rising demand for the emergency care, growth in the demand for the investment funds and the government initiative in improving the emergency care infrastructure are anticipated to drive the market for the airway management devices.

Lack of professionals and increasing pricing factor on the market are considered to be the biggest restraints for the market.

Depending on the type, the market is bifurcated into Infraglottic Laryngoscopes, Resuscitators, Supraglottic Airway Management Devices, Airway Management Device, and others. Infraglottic Airway Management Devices held the highest market share of 32% in 2018. Infraglottic Airway Management Devices segment was $403.7 million in 2018 and is estimated to generate a revenue of $662.4 million by 2026. Supraglottic Airway Management Devices has the highest growth rate in the forecast period. Supraglottic Airway Management Devices is predicted to grow at a CAGR of 8.3% and is estimated to generate a revenue of $466.3million by 2026.

Depending on the end use the market is bifurcated into Intensive Care Units, Emergency Care Departments, Operating Rooms, and Others. Operating rooms holds the highest market share of 38.9% in 2018. The operating room segment accounted for $ 478.8 million in 2018 and is estimated to generate a revenue of $823.6 million by 2026. Emergency Care Departments segment has the highest growth rate in the forecast period. Emergency Care Departments is predicted to grow at a CAGR of 7.9% and is estimated to generate a revenue of $499.0 million by 2026.

Depending on the patient’s age the market is bifurcated into Adult patient, and pediatric patient. Adult patient segment was $763.1 million in 2018 and is estimated to generate a revenue of $1,309.5 million by 2026. Pediatric patients segment was $ 467.7 million in 2018 and is estimated to generate a revenue of $869.3 million by 2026.

Depending on the region, the market is segregated into North America, Europe, Asia-Pacific and LAMEA. North America accounted for $504.6 million in 2018 and is estimated to generate a revenue of $875.9 million by 2026. Asia-Pacific region revenue was accounted for $196.9 million in 2018 and is estimated to generate a revenue of $359.5 million by 2026.

The major key players in this market are Salter Labs, SourceMark, VBM Medizintechnik, Vyaire Medical, SunMed, Intersurgical, Verathon, Flexicare, KARL STORZ, and Ambu, Teleflex among others

1. Research Methodology

1.1. Desk Research

1.2. Real time insights and validation

1.3. Forecast model

1.4. Assumptions and forecast parameters

1.4.1. Assumptions

1.4.2. Forecast parameters

1.5. Data sources

1.5.1. Primary

1.5.2. Secondary

2. Executive Summary

2.1. 360° summary

2.2. Type trends

2.3. Patient Age trends

2.4. End-use trends

3. Market Overview

3.1. Market segmentation & definitions

3.2. key takeaways

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of consumers

3.3.2. Bargaining power of suppliers

3.3.3. Threat of new entrants

3.3.4. Threat of substitutes

3.3.5. Competitive rivalry in the market

3.4. Market dynamics

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Opportunities

3.5. Patient Age landscape

3.6. Regulatory landscape

3.7. Patent landscape

3.8. Market value chain analysis

3.9. Strategic overview

4. Airway Management Devices Market, by Type

4.1. Infraglottic Airway Management Devices

4.1.1. Market size and forecast, by region, 2016-2026

4.1.2. Comparative market share analysis, 2018 & 2026

4.2. Supraglottic Airway Management Devices

4.2.1. Market size and forecast, by region, 2016-2026

4.2.2. Comparative market share analysis, 2018 & 2026

4.3. Resuscitators

4.3.1. Market size and forecast, by region, 2016-2026

4.3.2. Comparative market share analysis, 2018 & 2026

4.4. Laryngoscopes

4.4.1. Market size and forecast, by region, 2016-2026

4.4.2. Comparative market share analysis, 2018 & 2026

4.5. Others

4.5.1. Market size and forecast, by region, 2016-2026

4.5.2. Comparative market share analysis, 2018 & 2026

5. Airway Management Devices Market, by Patient Age

5.1. Adult Patient

5.1.1. Market size and forecast, by region, 2016-2026

5.1.2. Comparative market share analysis, 2018 & 2026

5.2. Pediatric Patient

5.2.1. Market size and forecast, by region, 2016-2026

5.2.2. Comparative market share analysis, 2018 & 2026

6. Airway Management Devices Market, by End-use

6.1. Operating Rooms

6.1.1. Market size and forecast, by region, 2016-2026

6.1.2. Comparative market share analysis, 2018 & 2026

6.2. Emergency Care Departments

6.2.1. Market size and forecast, by region, 2016-2026

6.2.2. Comparative market share analysis, 2018 & 2026

6.3. Intensive Care Units

6.3.1. Market size and forecast, by region, 2016-2026

6.3.2. Comparative market share analysis, 2018 & 2026

6.4. Others

6.4.1. Market size and forecast, by region, 2016-2026

6.4.2. Comparative market share analysis, 2018 & 2026

7. Airway Management Devices Market, by Region

7.1. North America

7.1.1. Market size and forecast, by Type, 2016-2026

7.1.2. Market size and forecast, by Patient Age, 2016-2026

7.1.3. Market size and forecast, by end-use, 2016-2026

7.1.4. Market size and forecast, by country, 2016-2026

7.1.5. Comparative market share analysis, 2018 & 2026

7.1.6. U.S.

7.1.6.1. Market size and forecast, by Type, 2016-2026

7.1.6.2. Market size and forecast, by Patient Age, 2016-2026

7.1.6.3. Market size and forecast, by end-use, 2016-2026

7.1.6.4. Comparative market share analysis, 2018 & 2026

7.1.7. Canada

7.1.7.1. Market size and forecast, by Type, 2016-2026

7.1.7.2. Market size and forecast, by Patient Age, 2016-2026

7.1.7.3. Market size and forecast, by end-use, 2016-2026

7.1.7.4. Comparative market share analysis, 2018 & 2026

7.1.8. Mexico

7.1.8.1. Market size and forecast, by Type, 2016-2026

7.1.8.2. Market size and forecast, by Patient Age, 2016-2026

7.1.8.3. Market size and forecast, by end-use, 2016-2026

7.1.8.4. Comparative market share analysis, 2018 & 2026

7.2. Europe

7.2.1. Market size and forecast, by Type, 2016-2026

7.2.2. Market size and forecast, by Patient Age, 2016-2026

7.2.3. Market size and forecast, by end-use, 2016-2026

7.2.4. Market size and forecast, by country, 2016-2026

7.2.5. Comparative market share analysis, 2018 & 2026

7.2.6. UK

7.2.6.1. Market size and forecast, by Type, 2016-2026

7.2.6.2. Market size and forecast, by Patient Age, 2016-2026

7.2.6.3. Market size and forecast, by end-use, 2016-2026

7.2.6.4. Comparative market share analysis, 2018 & 2026

7.2.7. Germany

7.2.7.1. Market size and forecast, by Type, 2016-2026

7.2.7.2. Market size and forecast, by Patient Age, 2016-2026

7.2.7.3. Market size and forecast, by end-use, 2016-2026

7.2.7.4. Comparative market share analysis, 2018 & 2026

7.2.8. France

7.2.8.1. Market size and forecast, by Type, 2016-2026

7.2.8.2. Market size and forecast, by Patient Age, 2016-2026

7.2.8.3. Market size and forecast, by end-use, 2016-2026

7.2.8.4. Comparative market share analysis, 2018 & 2026

7.2.9. Spain

7.2.9.1. Market size and forecast, by Type, 2016-2026

7.2.9.2. Market size and forecast, by Patient Age, 2016-2026

7.2.9.3. Market size and forecast, by end-use, 2016-2026

7.2.9.4. Comparative market share analysis, 2018 & 2026

7.2.10. Italy

7.2.10.1. Market size and forecast, by Type, 2016-2026

7.2.10.2. Market size and forecast, by Patient Age, 2016-2026

7.2.10.3. Market size and forecast, by end-use, 2016-2026

7.2.10.4. Comparative market share analysis, 2018 & 2026

7.2.11. Rest of Europe

7.2.11.1. Market size and forecast, by Type, 2016-2026

7.2.11.2. Market size and forecast, by Patient Age, 2016-2026

7.2.11.3. Market size and forecast, by end-use, 2016-2026

7.2.11.4. Comparative market share analysis, 2018 & 2026

7.3. Asia-Pacific

7.3.1. Market size and forecast, by Type, 2016-2026

7.3.2. Market size and forecast, by Patient Age, 2016-2026

7.3.3. Market size and forecast, by end-use, 2016-2026

7.3.4. Market size and forecast, by country, 2016-2026

7.3.5. Comparative market share analysis, 2018 & 2026

7.3.6. China

7.3.6.1. Market size and forecast, by Type, 2016-2026

7.3.6.2. Market size and forecast, by Patient Age, 2016-2026

7.3.6.3. Market size and forecast, by end-use, 2016-2026

7.3.6.4. Comparative market share analysis, 2018 & 2026

7.3.7. Japan

7.3.7.1. Market size and forecast, by Type, 2016-2026

7.3.7.2. Market size and forecast, by Patient Age, 2016-2026

7.3.7.3. Market size and forecast, by end-use, 2016-2026

7.3.7.4. Comparative market share analysis, 2018 & 2026

7.3.8. India

7.3.8.1. Market size and forecast, by Type, 2016-2026

7.3.8.2. Market size and forecast, by Patient Age, 2016-2026

7.3.8.3. Market size and forecast, by end-use, 2016-2026

7.3.8.4. Comparative market share analysis, 2018 & 2026

7.3.9. Australia

7.3.9.1. Market size and forecast, by Type, 2016-2026

7.3.9.2. Market size and forecast, by Patient Age, 2016-2026

7.3.9.3. Market size and forecast, by end-use, 2016-2026

7.3.9.4. Comparative market share analysis, 2018 & 2026

7.3.10. South Korea

7.3.10.1. Market size and forecast, by Type, 2016-2026

7.3.10.2. Market size and forecast, by Patient Age, 2016-2026

7.3.10.3. Market size and forecast, by end-use, 2016-2026

7.3.10.4. Comparative market share analysis, 2018 & 2026

7.3.11. Rest of Asia-Pacific

7.3.11.1. Market size and forecast, by Type, 2016-2026

7.3.11.2. Market size and forecast, by Patient Age, 2016-2026

7.3.11.3. Market size and forecast, by end-use, 2016-2026

7.3.11.4. Comparative market share analysis, 2018 & 2026

7.4. LAMEA

7.4.1. Market size and forecast, by Type, 2016-2026

7.4.2. Market size and forecast, by Patient Age, 2016-2026

7.4.3. Market size and forecast, by end-use, 2016-2026

7.4.4. Market size and forecast, by country, 2016-2026

7.4.5. Comparative market share analysis, 2018 & 2026

7.4.6. Brazil

7.4.7. Market size and forecast, by Type, 2016-2026

7.4.8. Market size and forecast, by Patient Age, 2016-2026

7.4.9. Market size and forecast, by end-use, 2016-2026

7.4.10. Comparative market share analysis, 2018 & 2026

7.4.11. Saudi Arabia

7.4.11.1. Market size and forecast, by Type, 2016-2026

7.4.11.2. Market size and forecast, by Patient Age, 2016-2026

7.4.11.3. Market size and forecast, by end-use, 2016-2026

7.4.11.4. Comparative market share analysis, 2018 & 2026

7.4.12. South Africa

7.4.12.1. Market size and forecast, by Type, 2016-2026

7.4.12.2. Market size and forecast, by Patient Age, 2016-2026

7.4.12.3. Market size and forecast, by end-use, 2016-2026

7.4.12.4. Comparative market share analysis, 2018 & 2026

7.4.13. Rest of LAMEA

7.4.13.1. Market size and forecast, by Type, 2016-2026

7.4.13.2. Market size and forecast, by Patient Age, 2016-2026

7.4.13.3. Market size and forecast, by end-use, 2016-2026

7.4.13.4. Comparative market share analysis, 2018 & 2026

8. Company Profiles

8.1. Medtronic

8.1.1. Business overview

8.1.2. Financial performance

8.1.3. Type portfolio

8.1.4. Recent strategic moves & developments

8.1.5. SWOT analysis

8.2. Smiths Medical

8.2.1. Business overview

8.2.2. Financial performance

8.2.3. Type portfolio

8.2.4. Recent strategic moves & developments

8.2.5. SWOT analysis

8.3. Teleflex

8.3.1. Business overview

8.3.2. Financial performance

8.3.3. Type portfolio

8.3.4. Recent strategic moves & developments

8.3.5. SWOT analysis

8.4. KARL STORZ SE & Co. KG

8.4.1. Business overview

8.4.2. Financial performance

8.4.3. Type portfolio

8.4.4. Recent strategic moves & developments

8.4.5. SWOT analysis

8.5. AMBU A/S.

8.5.1. Business overview

8.5.2. Financial performance

8.5.3. Type portfolio

8.5.4. Recent strategic moves & developments

8.5.5. SWOT analysis

8.6. Flexicare Medical Limited

8.6.1. Business overview

8.6.2. Financial performance

8.6.3. Type portfolio

8.6.4. Recent strategic moves & developments

8.6.5. SWOT analysis

8.7. Intersurgical Ltd

8.7.1. Business overview

8.7.2. Financial performance

8.7.3. Type portfolio

8.7.4. Recent strategic moves & developments

8.7.5. SWOT analysis

8.8. SunMed

8.8.1. Business overview

8.8.2. Financial performance

8.8.3. Type portfolio

8.8.4. Recent strategic moves & developments

8.8.5. SWOT analysis

8.9. VYAIRE MEDICAL, INC.

8.9.1. Business overview

8.9.2. Financial performance

8.9.3. Type portfolio

8.9.4. Recent strategic moves & developments

8.9.5. SWOT analysis

8.10. Vbm Medizintechnik

8.10.1. Business overview

8.10.2. Financial performance

8.10.3. Type portfolio

8.10.4. Recent strategic moves & developments

8.10.5. SWOT analysis

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research